Stock market update: Brussels remains in the red
(ABM FN) The Brussels stock exchange remained in the red on Tuesday afternoon. The Bel20, 0.3 percent to 4,31389 points.
In the main index, insurer Ageas led the way with a gain of 3.6 percent. KBC fell 3.7 percent, despite price target increases by Deutsche Bank, UBS and Credit Suisse.
In the BelMid, Bois Sauvage rose 2.2 percent, IBA 2.3 percent revision.
A new study shows that the Idylla EGFR mutation test from diagnostics company Biocartis has saved time. The stock rose 1.3 percent.
Among the smaller BelSmall stocks, Crescent rose 4.3 percent. Nyxoah fell 3.6 percent.
Greenyard reported good first half results and maintained its outlook. According to Degroof Petercam, this means that the company’s profitability is stabilizing. The stock rose 1.9 percent.
Outside the indexes, attention was mainly focused on Azelis, which fell by 2.5 percent, despite the good quarterly results of the new stock market.
Source: ABM Financial News
From Beursplein 5, the editors of Financial news from ABM keep a close eye on developments on the stock exchanges, and the Amsterdam stock exchange in particular. The information in this column is not intended as professional investment advice or as a recommendation to make.